MSB 2.26% 90.5¢ mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-758

  1. 144 Posts.
    lightbulb Created with Sketch. 75
    The question is does ASIC have the capability and expertise to monitor and execute remedies to instill confidence. They do have highly complex regulatory powers to enforce the laws and regulations that govern financial markets in Australia. The Royal Commission into the financial sector seems to of focussed on the banks and somewhat Superannuation, ASX maybe too complex and lacking in expertise or professional lobbyist far too influential in shaping the landscape. it's become a mugs game with greed sucking in the gullible with high returns and riches eg, ten baggers. However, Mesoblast in my opinion may just be that great little Aussie Company offering hope and alternatives to the current invasive operations.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
90.5¢
Change
0.020(2.26%)
Mkt cap ! $1.033B
Open High Low Value Volume
88.5¢ 95.0¢ 88.0¢ $5.610M 6.115M

Buyers (Bids)

No. Vol. Price($)
12 317774 90.0¢
 

Sellers (Offers)

Price($) Vol. No.
91.5¢ 23500 2
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.